Searched for
DIRECTOR YK HAMIED
Cipla global CEO Umang Vohra to step down; Achin Gupta to take overCipla's global CEO Umang Vohra will step down in March 2026. Achin Gupta, currently global COO, will take over as the new MD and GCEO from ...- Cipla's vice-chairman MK Hamied resigns citing age and health, his son Kamil to join the boardCipla's vice-chairman MK Hamied has resigned from the board due to age and health concerns, effective October 29, 2024. His son Kamil Hamie...
- Torrent joins fray for Hamied family stake in Cipla, up against Blackstone and Baring PETorrent Pharma is reportedly vying to acquire the Hamied family's stake in Cipla, which could become the largest pharmaceutical deal since ...
- Epic saga of Cipla: How a swadeshi Robin Hood took on Big Pharma of the WestCipla has been closely associated with India's struggle for independence, with Khwaja Abdul Hamied forming the company in 1935. For the Big...
- Cipla is undergoing a big transformation and is doing something it once eschewedA difficult transformation is underway at Cipla, one of India’s largest and oldest pharma companies.
- Cipla names Samina Vaziralli as Executive Vice-ChairmanVaziralli, daughter of MK Hamied -- the company's non-executive VC - has been a part of the core leadership team since joining the Mumbai-b...
- Need more women on boards? Hire a female CEO“Women CEOs show an enlightened attitude to boards and promoters. A greater gender diversity at board level is a desirable outcome for comp...
- YK Hamied to increase stake in Cipla to over 20 per centCipla patriarch YK Hamied plans to increase his holding to over 20 per cent by acquiring over 5 per cent additional stake in the homegrown ...
- InvaGen, Exelan acquisition will give Cipla manufacturing plant, R&D base in USCipla on Friday fulfilled a longstanding desire to expand its beachhead in the US by buying Hetero Pharma’s US business for about $550 mill...
- Fidelity invests in Cipla’s consumer healthcare businessFidelity Growth Partners India and Fidelity Biosciences have invested an undisclosed sum in Indian drug maker Cipla’s newly floated consume...
- Budget 2015: AAP triumph will not make Modi government go into populist mode, say CEOsThe stunning win of AAP will not result in the Modi administration switching policies in a more populist direction, according to a survey o...
- Corporate India sees old guard making way for next line execsOberoi in his new role as 'Executive Chairman' will look after the renovations of existing hotels and future projects.
- Cipla set to buy 51% of S Africa's Cipla Medpro for about $220 millionCipla said on Wednesday it will buy 51% of Cipla Medpro for about $220 million, valuing the beleaguered South African company at about $440...
- Cipla slashes prices of 3 cancer drug by up to 63%The company said on Thursday that its lung cancer drug Erlocip would cost Rs 9,900 for 30 tablets instead of Rs 27,000 and Rs 3,700 for 10 ...
- Cipla looking to expand contraceptive pills business; in talks with International Planned ParenthoodThe country's second-largest pharmaceuticals company, Cipla, is in talks with an international health group to expand its contraceptive pil...
- Cipla shocks rivals by slashing cancer drug prices up to 75%Kidney cancer drug will now be available at Rs 6,840 for a month's supply, down from Rs 28,000. Lung cancer drug will cost Rs 4,250, down f...
- Cipla promoters not selling out,Co plans to scale up revenuesPharma major Cipla on Thursday said it is expecting to scale up its revenue by over six times to Rs 15,000-20,000 crore.
- CEOs ready to rock with Samba BoysMost top Indian businessmen and CEOs are backing traditional favourites Brazil, closely followed by England for the Soccer WC next month, a...
- Pharma cos want new govt to boost spending, push reformsThe UPA government should scale up government spending on the pharma industry and it should also take measures conducive to research and de...
- Cipla sidesteps succession issue, to focus on aggressive expansionThe lack of clarity on the succession issue may have impacted the functioning of many family-owned Indian companies. But the septuagenarian...
Load More
